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Despite the significant impacts on human health caused by neurodegeneration, our understanding of the degeneration 
process is incomplete. The nematode Caenorhabditis elegans is emerging as a genetic model organism well suited for 
identification of conserved cellular mechanisms and molecular pathways of neurodegeneration. Studies in the worm 
have identified factors that contribute to neurodegeneration, including excitotoxicity and stress due to reactive oxygen 
species (ROS). Disruption of the gene unc-68, which encodes the ryanodine receptor, abolishes excitotoxic cell death, 
indicating a role for calcium (Ca2+) signaling in neurodegeneration. We tested the requirement for unc-68 in ROS-
mediated neurodegeneration using the genetically encoded photosensitizer KillerRed. Upon illumination of KillerRed 
expressing animals to produce ROS, we observed similar levels of degeneration in wild-type and unc-68 mutant strains. 




Neurons are the primary functional cell of the nervous system. The 
human brain contains ~86 billion neurons (Azevedo et al., 2009) 
that form countless synapses and mediates complex processes such 
as physiological regulation, behavior, and consciousness. Neurons 
of the central nervous system are subject to neurodegeneration, 
which results in the progressive loss of neuronal function and 
ultimately neuronal death. Many neurodegenerative diseases, such 
as Alzheimer’s disease and Parkinson’s disease, are characterized 
by neurodegeneration of selective brain regions and are becoming 
increasingly common. Although genes and environmental factors 
that contribute to neurodegeneration have been identified (Xie et 
al., 2014), the cellular pathways and molecular mechanisms that 
underlie the degenerative process are poorly understood.   
 Reactive oxygen species (ROS) are implicated in many different 
neurodegenerative diseases, but their contribution to the 
degenerative process is not well established (Labunskyy and 
Gladyshev, 2013). ROS are a diverse family of oxygen molecules 
with unpaired electrons produced as natural byproducts of 
mitochondrial electron transport. Because of the unpaired electron, 
ROS are highly reactive and oxidize macromolecules such as 
proteins, nucleic acids, and lipids resulting in disruption of cellular 
function . Cells possess multiple lines of defense against ROS, 
such as detoxifying enzymes and small molecule antioxidants 
(Chang et al., 2008). ROS-mediated neurodegeneration results 
from oxidative stress due to increased levels of ROS or decreased 
ability to respond to increased ROS production (Chakraborty et al., 
2013). Although ROS can be damaging to cells and are associated 
with degeneration, signaling pathways involved in ROS-mediated 
neurodegeneration have not been identified. 
 Caenorhabditis elegans is an established model organism that 
is well-suited to identify and characterize molecular mechanisms 
of neuronal function and dysfunction (Li and Le, 2013). This 
nematode has a short life cycle of three days and can be easily 
propagated in the laboratory. In addition, worms have a simple, yet 
well-defined nervous system of 302 neurons that mediate readily 
observable behaviors (Hart, 2006). The worm is transparent and 
transgenes that drive tissue-specific fluorescent reporters can be 
introduced and used to visualize neuronal morphology in living 
animals. There are a number of strains that have mutations in 
specific genes, allowing researchers to use a genetic approach to 
infer the function of specific genes by examining the phenotypic 
consequences of gene mutation. Finally, many genes are conserved 
between worms and humans. Because of these features, the worm 
has been used to model different aspects of human 
neurodegenerative diseases (Dimitriadi and Hart, 2010).  
 Using worms as a model of neurodegeneration, multiple labs 
have demonstrated that calcium (Ca2+) has an important functional 
role in the degenerative processes. The constitutively open ion 
channel mec-4(d) causes degeneration in a manner that resembles 
excitotoxic neurodegeneration (Driscoll and Chalfie, 1991). 
Mutations that affect calcium release from ER stores or 
pharmacological perturbation of cytoplasmic Ca2+ levels prevent 
med-4(d) degeneration (Xu et al., 2001). Genetic ablation of 
coenzyme Q biosynthesis causes degeneration of a specific class 
of motor neuron in a Ca2+ dependent manner (Earls et al., 2010). 
In addition, pharmacological manipulation of Ca2+ release from the 
ER delays neurodegeneration in a worm model of amyotrophic 
lateral sclerosis (Aggad et al., 2014). Collectively, these 
experiments suggest that Ca2+ signaling is part of the degenerative 
process, but the role of Ca2+ signaling has not been established for 
ROS-mediated neurodegeneration.   
 We examined the requirement of Ca2+ in ROS-mediated 
neurodegeneration using optogenetic production of ROS in 
specific neurons of C. elegans. Specifically, we expressed the 
genetically encoded photosensitizer KillerRed in the GABA 
nervous system of worms. Killer Red is a modified fluorescent 
protein that produces large amounts of ROS when illuminated 
(Bulina et al., 2006). Illumination of worms that express KillerRed 
in neurons results in cell autonomous neurodegeneration and cell 
death (Williams et al., 2013). We used KillerRed to trigger ROS-
mediated neurodegeneration of neurons that use the 
neurotransmitter γ-aminobutyric acid (GABA). These motor 
neurons form inhibitory neuromuscular junctions with body-wall 
muscles and mediate muscle relaxation during locomotion 
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(McIntire et al., 1993; Schuske et al., 2004). When wild-type 
worms are lightly tapped on the head, they respond by moving 
backwards. By contrast, worms that are defective in GABAergic 
neurotransmission lack the ability to relax muscles. This results in 
a distinctive shrinker phenotype when lightly tapped on the head, 
due to longitudinal muscle contraction. Because of this distinct 
phenotype due to GABA neuron loss, we used the shrinker 
phenotype to assay ROS-mediated neurodegeneration that resulted 
from KillerRed activation.  
 A genetic approach was used to determine the role of Ca2+ in 
neurodegeneration by assaying neurodegeneration in animals that 
have mutations in a gene necessary for Ca2+ homeostasis. The unc-
68 gene encodes for the ryanodine receptor, which is critically 
involved in Ca2+ release from the ER (Maryon et al., 1996). 
Mutations in unc-68 alter Ca2+ release and are able to suppress 
excitotoxic neurodegeneration caused by the open ion channel 
mec-4(d) (Xu et al., 2001). We employed a similar genetic 
approach to test the involvement of Ca2+ in ROS-mediated 
degeneration by comparing KillerRed-mediated 




C. elegans maintenance and strains 
 
 Worms were cultured at 20°C and maintained on NGM using 
standard techniques (Stiernagle, 2006). Strains expressing 
KillerRed and GFP in GABA neurons have been described 
previously (McIntire et al., 1997; Williams et al., 2013) and were 
obtained from Marc Hammarlund, Yale University. The alleles of 
unc-68 (r1161 and e540), as well as the unc-47(e307), which 
encodes the vesicular GABA transporter (McIntire et al., 1997), 
were obtained from the Caenrohabditis Genome Center, 
University of Minnesota. Relevant strains were generated by 
crossing, verifying genotype by direct visualization of 
fluorescence (GFP and KillerRed) and by observation of 
uncoordinated phenotype (unc-68). The unc-68(r1161) allele 
(Maryon et al., 1996) was verified by polymerase chain reaction 
using the primers unc-68 FW (5’ 
AAATTGCAGCCCGAAAGACG 3’)  and unc-68 REV (5’ 
CAACCAATCGCCAATCCTGC 3’). 
 
Worm illumination to activate KillerRed 
  
 Worms were illuminated using an Olympus BX51 microscope 
equipped with an arc-lamp and TRITC filters. L4 worms were 
placed in the lid of an inverted PCR tube containing 29µl of 8% 
agarose and 21µl of 1X M9. Samples were placed on a microscope 
stage and focused using white light. Using the TRITC filter, worms 
were illuminated with green light for 10 minutes. After 
illumination, worms were recovered on new NGM plates and 
analyzed for neurodegeneration 24 hours after illumination. 
 
Scoring by GABA phenotype 
 
 The shrinker phenotype was used to assay GABA neuron 
function and quantify neurodegeneration. Worms on NGM plates 
were lightly tapped on the head and scored for response. Normal 
backward motion was scored as a wild-type response, while a 
contraction of the body in response to stimuli was scored as a 
shrinker response. Data presented is the percentage of animals 




Activation of KillerRed causes neurodegeneration 
 
 To establish that activation of KillerRed leads to ROS-mediated 
neurodegeneration, we measured degeneration of KillerRed 
expressing worms upon illumination. Worms that express 
KillerRed in the GABA neurons were subject to illumination, or 
kept in the dark. One day after treatment, animals were analyzed 
for loss of GABA neuron function by analyzing the shrinker 
phenotype. Animals were scored by determining the percentage 
that responded with normal backwards movement (nonshrinker) or 
displayed longitudinal body muscle contractions (shrinker) when 
lightly tapped on the head. We observed a higher percentage of 
animals that displayed the shrinker phenotype after illumination 
compared to unilluminated controls (Figure 1A). Upon 
illumination, 60% of the worms displayed the shrinker phenotype, 
compared to 25% of worms kept in the dark. This result indicates 
that KillerRed activation causes a reduction in neuronal function 
that is likely due to neurodegeneration. Although KillerRed 
animals have a slight shrinker phenotype in the absence of 
illumination (compare Figure 1 to Figure 2), this is likely a 
consequence of the KillerRed transgene (see discussion)  
 To verify that KillerRed elicits neurodegeneration, we 
examined neuronal structure by fluorescence microscopy. Animals 
that express both KillerRed and GFP in the GABA neurons were 
illuminated or kept in the dark, and then the structural integrity of 
the nervous system was analyzed by visualization of GFP. The 
neurodegenerative effects of KillerRed activation were seen in 
illuminated animals (Figure 1B). The nerve cords of these animals 
were disrupted and fragmented, while the cell bodies had a rounded 
morphology that is characteristic of neurodegeneration (Hall et al., 
1997). In addition, the commissures of these animals were very 
thin and often had breaks in them (data not shown). By contrast, 
control animals kept in the dark had intact nerve cords and cell 
bodies with normal oval-shaped morphology. Thus, activation of 
KillerRed induces functional and structural neurodegeneration and 
provides a tool to genetically dissect ROS-mediated 
neurodegeneration by comparing the effects of KillerRed in 
different genetic backgrounds.  
 
unc-68 mutants are not GABA defective 
 
 In order to test whether unc-68 mutants have defective 
neurodegeneration we first had to establish that unc-68 mutants 
have normal GABA function in the absence of KillerRed. As we 
measure neurodegeneration by scoring ablation of GABA neurons 
via the shrinker phenotype, we tested whether unc-68 mutants are 
shrinker (Figure 2). Wild-type, unc-68(r1161) and GABA- (unc-
47(e307)) animals were scored by determining the percentage of 
age-matched animals that were shrinker. 6% of wild-type worms 
were shrinker, while GABA- worms displayed a 79% shrinker 





animals showed a 5% shrinker rate. Because unc-68 mutant 
animals do not have a GABA defect, we can determine whether 
ROS-mediated neurodegeneration requires unc-68 function using 
KillerRed expressed in GABA neurons. 
  
Neurodegeneration is not affected by mutations in unc-68 
 
 To assess the role of unc-68 in ROS-mediated 
neurodegeneration, we generated unc-68 mutants that express 
KillerRed in the GABA neurons. Genotypic verification was done 
by single worm PCR reactions to amplify the unc-68 gene in both 
wild-type and unc-68(r1161) animals. The expected 8172 base pair 
product was seen upon amplification of wild-type animals. A much 
smaller product of ~970 base pairs was obtained when unc-
68(r1161) animals were amplified (Figure 3), consistent with the 
~7.2 kilobase pair deletion of the r1161 allele (Maryon et al., 
1996). Because the molecular lesion of unc-68(e540) has not been 
determined, strains of this genotype were verified by visual 
observation of the uncoordinated phenotype.  
 After verifying the genotype of generated strains, we assayed 
KillerRed-mediated neurodegeneration of wild-type worms and 
unc-68 mutants (Figure 4). Illumination resulted in a similar 
percentage of shrinker animals in wild-type (134/222 = 60%) and 
unc-68 animals (116/221 = 52%). Both alleles of unc-68 that were 
tested (r1161 and e540) had similar levels of neurodegeneration. 
Because there is a similarity of the shrinker frequencies between 
illuminated animals of wild-type and unc-68 mutants, these results 
indicate there are similar levels of neurodegeneration in both 
strains and that ROS-mediated neurodegeneration is independent 




 C. elegans is an ideal system to study ROS-mediated 
neurodegeneration due to ease of propagation, well-characterized 
nervous system with specific behavioral outcomes, and ability to 
express heterologous transgenes in a tissue specific manner. 
Worms are small, easy to culture in a laboratory setting, and large 
numbers of genetically identical animals can be readily obtained. 
The nervous system of C. elegans is simple compared to 
mammalian nervous systems and specific behaviors can be 
attributed to specific neuron types, allowing for direct study of 
neuronal function (Hart, 2006). Many genes and molecular 
mechanisms are conserved between worms and mammals. In 
addition, the ability to express heterologous transgenes allows 
targeting of neurodegenerative insults, such as ROS, in a tissue-
specific manner. Because of this, C. elegans provides a simple 
manipulation platform to investigate neurodegeneration in a 
system with similar neuron structure and complex pathways with 
humans (Alexander et al., 2014). 
 To test whether Ca2+ signaling is involved in ROS-mediated 
neurodegeneration, we used KillerRed expressed in GABA 
neurons to specifically produce ROS in these cells and measured 
degeneration in wild-type and unc-68 mutants. Neurodegeneration 
was assayed by the shrinker phenotype that is caused by loss of 
GABA neurons. We can use this assay because unc-68 mutants do 
not have the shrinker phenotype in the absence of KillerRed. 
Activation of KillerRed results in a robust shrinker phenotype in  
 
Figure 1.  KillerRed activation causes neurodegeneration. 
(A) KillerRed expressing animals were illuminated or kept 
in the dark (Control), then scored for GABA neuron 
function by determining the percentage of animals that 
displayed the shrinker phenotype. Data presented is the 
percentage of shrinkers ± 95% confidence intervals. 
Illumination resulted in a significant increase in the 
shrinker frequency. (B) Representative images of the 
nervous system from illuminated and control animals 
obtained imaged by fluorescent microscopy. Illumination 
resulted in beading of ventral and dorsal cords (arrows) as 
well as rounding of cell bodies (asterisk) that is 
characteristic of neurodegeneration. 
 
Figure 2. unc-68 mutants are not GABA defective. The 
indicated types of worms were scored for the shrinker 
phenotype. Data presented is the frequency of shrinkers ± 
95% confidence intervals. At least 30 worms were scored 
for each experiment. Wild-type and unc-68 mutant worms 
do not display the shrinker phenotype. By contrast GABA- 
worms, unc-47(e307) mutants, have a robust highly 




both wild-type and unc-68 mutant backgrounds. There is a slight 
shrinker phenotype to KillerRed worms that are kept in the dark 
(~25%), compared to worms that do not express KillerRed (~6%). 
This is likely do to the presence of the KillerRed transgenic 
construct that is made up of multiple copies of the GABA specific 
promoter driving KillerRed. Other transgenes that have the same 
promoter fused to other neutral reporter genes, such as GFP, also 
have a slight shrinker phenotype (D. Williams, personal 
observations).  
 When we compared wild-type to unc-68 mutants, similar levels 
of neurodegeneration were seen in both genetic backgrounds, 
indicating that UNC-68 is not required for ROS-mediated 
neurodegeneration. Our results are in contrast to previous studies 
that indicated a role for Ca2+ signaling as part of a 
neurodegenerative pathway by demonstrating unc-68 mutations 
suppress neurodegeneration (Earls et al., 2010; Xu et al., 2001). 
This suggests there are multiple pathways of neurodegeneration 
that differ in their Ca2+ dependence (Figure 5). The targets of Ca2+ 
during excitotoxic degeneration are Ca2+ dependent calpain 
proteases that mediate autophagy like processes as the neuron 
degenerates (Syntichaki et al., 2002). As the cellular pathology of 
ROS mediated neurodegeneration and excitotoxic degeneration are 
similar (Hall et al., 1997; Williams et al., 2013), our results suggest 
that ROS could activate calcium independent proteases. 
Alternatively, there could be other means of Ca2+ release from the 
ER in the absence of UNC-68. Further genetic analysis with 
mutations in other genes that affect Ca2+ or pharmacological 
manipulation of Ca2+ levels could be used to distinguish between 
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Figure 4. unc-68 mutants are not defective in KillerRed-
mediated neurodegeneration Wild-type and unc-68 mutant 
animals were illuminated (+) or kept in the dark (-), then 
scored for the shrinker phenotype. Data presented in the 
frequency of shinker animals ± 95% confidence intervals. At 
least 100 animals were scored for each condition and unc-68 
mutants represent a pool of e540 and r1161 alleles, both of 
which had similar levels of neurodegeneration. 
 
 
Figure 5. Multiple pathways of neurodegeneration in C. 
elegans. ROS, excitotoxicity, and mitochondrial dysfunction 
can lead to neurodegeneration through molecular pathways that 
differ in their dependence on Ca2+. 
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